PFE Dec 2025 20.000 call
| Previous close | 9.55 |
| Open | 9.34 |
| Bid | 8.65 |
| Ask | 11.10 |
| Strike | 20.00 |
| Expiry date | 2025-12-19 |
| Day's range | 9.34 - 10.00 |
| Contract range | N/A |
| Volume | |
| Open interest | 2.03k |
BloombergSecond US Human Bird Flu Infection Reported in Michigan
(Bloomberg) -- A Michigan farmworker tested positive with bird flu, the second person to contract the potentially lethal virus that has run rampant in US cattle.Most Read from BloombergNvidia Stock Surges as Sales Forecast Delivers on AI HopesThese Flight Routes Suffer the World’s Worst TurbulenceCiti Trader Got 711 Warning Messages Before Sparking Flash CrashHarvard Defies Faculty Vote to Block 13 Students From GraduatingUS Justice Department to Seek Breakup of Live Nation-TicketmasterThe farmw
Barrons.comCDC Confirms a Second Bird Flu Case in U.S. Dairy Worker. Vaccine Momentum Builds.
U.S. officials said Wednesday that a Michigan dairy worker had tested positive for avian influenza, the second known human case in the U.S. since the virus was detected in late March in cattle. The Centers for Disease Control and Prevention said that the patient only had eye symptoms, similar to the first known infected dairy worker, who developed conjunctivitis in Texas in March. The CDC said that it still considers the risk from the current outbreak to the general public to be low.
ReutersPfizer rolls out another cost-cutting program, sets $1.5 billion target by 2027
Investors have fled from Pfizer as pandemic worries declined and billions of dollars in COVID-19 vaccine and treatment sales disappeared. Pfizer's shares were up 2.6% at $29.30 in afternoon trading. Pfizer made the disclosure on Wednesday in a filing with the Securities and Exchange Commission.
